(Q36473134)

English

A study of intranasally administered interferon A (rIFN-alpha 2A) for the seasonal prophylaxis of natural viral infections of the upper respiratory tract in healthy volunteers

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

A study of intranasally administered interferon A (rIFN-alpha 2A) for the seasonal prophylaxis of natural viral infections of the upper respiratory tract in healthy volunteers (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

author name string

G A Tannock

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

S M Gillett

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

R S Gillett

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

R D Barry

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

M J Hensley

5

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

R Herd

6

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

A L Reid

7

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

N A Saunders

8

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

publication date

1 December 1988

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Epidemiology and Infection

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

101

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

611-621

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2249423

30 September 2017

Rhinovirus colds

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2249423

30 September 2017

Antiviral Activity of Intranasally Applied Human Leukocyte Interferon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2249423

30 September 2017

Inhibition of respiratory virus infection by locally applied interferon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2249423

28 June 2018

Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2249423

28 June 2018

Intranasal interferon-alpha 2 prophylaxis of natural respiratory virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2249423

28 June 2018

Generalized Linear Models

1 reference

https://api.crossref.org/works/10.1017%2FS0950268800029484

21 January 2018

Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli

1 reference

https://pubmed.ncbi.nlm.nih.gov/3215290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intranasal Interferon 2 for Prevention of Rhinovirus Infection and Illness

1 reference

https://pubmed.ncbi.nlm.nih.gov/3215290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intranasally applied recombinant leukocyte A interferon in normal volunteers. II. Determination of minimal effective and tolerable dose

1 reference

https://pubmed.ncbi.nlm.nih.gov/3215290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intranasal interferon (rIFN-alpha A, Ro 22-8181) for contact prophylaxis against common cold: a randomized, double-blind and placebo-controlled field study

1 reference

https://pubmed.ncbi.nlm.nih.gov/3215290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylactic efficacy and tolerance of low-dose intranasal interferon-alpha 2 in natural respiratory viral infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/3215290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The interferons

1 reference

https://pubmed.ncbi.nlm.nih.gov/3215290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/3215290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intranasal interferon-alpha 2b for seasonal prophylaxis of respiratory infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/3215290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1017/S0950268800029484

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36473134&oldid=1518398999"